FDA Lowers the Bar for Drugs—While Raising It for Natural Health
The federal government just revealed, once again, where its priorities lie. Listen to the audio version of this article: THE TOPLINE In a move announced in the New England Journal of Medicine, the FDA says it will drop its long-standing expectation that new drugs be supported by two clinical trials, shifting instead to a “default” […]









